Armistice Capital Voting on AYTU (AYTU) and Innovus (INNV) Merger.
13D Filing on AYTU (As of the date hereof, each of the Reporting Persons may be deemed to be the beneficial owner of 7,695,064...
Innovus (INNV) Gains 75% in Past Week.
After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU).
Click here to receive post-merger report.
INNOVUS LIVE CHART
TRADING...
Newsworthy: Fortress Bio (FBIO) $1.73, Gets $20 Price Target!
Adding Fortress to Biotech Stock Review Watch List @ $1.73.
Misunderstood by Wall Street which tends to 'over-analyze' on occasion, we think the Fortress Bio...
SEC Charges TherapeuticsMD (TXMD) $2.80 With Regulation FD Violations
Washington D.C., Aug. 20, 2019 —
The Securities and Exchange Commission today charged TherapeuticsMD Inc., a pharmaceutical company headquartered in Boca Raton, Florida, with violations...
Emerald Organic Products, Inc. (EMOR) Announces Exclusive Licensing Agreement With PetVivo Holdings Inc. (PETV).
New York, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. (OTC:EMOR) ("Emerald" or the "Company") is pleased to announce that it...
Biotech Stock Review Adding PetVivo (PETV) $0.23 to the Watch List.
Are We Catching a Falling Knife?
Don't Think So!
LIVE QUOTE
2019 CHARTWhile No One Would Want an EKG Reading Like This..
LONG TERM CHARTThe Long Term...
Biotech Stock Review Adds NanoVibronix (NAOV) $2.95, to Watch List.
NanoVibronix Announces Closing of $3.2 Million Private Placement to Existing Shareholders.
Adding to Watch List @ $2.95* on Post-Offering Dip. We Would say our Timing...
Mustang Bio (MBIO) $3.40 Gets $7 Price Target from Cantor. (SeekingAlpha.)
June. 20, 2019 4:30 PM ET|About: Mustang Bio, Inc. (MBIO)|By: Jason Aycock, SA News Editor
Mustang Bio (NASDAQ:MBIO) is up 8.6% after hours following an initiation at Overweight...
Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation.
Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation for Development and Commercialization of Virtue® Sirolimus-Eluting Balloon.
June 13, 2019
Virtue® SEB is expected to become a flagship...
Innovus (INNV) Hits the Trifecta. Stuffy Noses, Hair Loss & Heartburn.
Innovative Innovus now has Three Shots on Goal with non-prescription drugs which have come off patent including a new competitor to Prilosec ® ....
Latest article
National Investment Bankers Conference
Companies Scheduled to Present
Since 1982, The National Investment Banking Association (NIBA) has been serving the micro-cap and small-cap investment community. They have hosted 150...
Report: Sekur Private Data (SWISF) Awarded Place on GSA Schedule.
This Week's GSA Announcement Marks Sekur’s 4th Major Milestone.
GSA Approval is akin to an electrician just starting out in the business, and being told...
Halted Stocks Watch List
We are following Companies which have been suspended by the SEC and will update news related to them here. In near real time.
To...
